BridgeMD
Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
EU CTIS ID: 2024-513033-21-00
What this study is testing
To monitor participants for delayed AEs associated with administration of autologous cells that have been genetically modified.
- Human Pharmacology (Phase I)- Other
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 1. Participants who have received at least one dose of ADP adoptive cell therapy agent.
- 2. Participants who have completed ADP sponsored or supported interventional study or have withdrawn from it.
- 3. Participants who have completed treatment as part of managed access to an adoptive cell therapy.
- 4. Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.
- 5. The investigator is responsible for review of medical history.
- 6. Capable of giving signed informed consent.
You likely can't join if
- None
The study team makes the final eligibility decision.
Where it's taking place
- Canada
- United States
- United Kingdom
- Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Canada; United States; United Kingdom; Australia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.